Drug cos want govt to review price control on key brands

Drug majors including Ranbaxy, Pfizer, Glaxo and Eli Lilly have approached the government asking for a review of the drug price regulator’ decision to impose price control on their key brands which include cough syrups, antibiotics, pain killers, ulcer treatments and pills for male impotence.

The major MNC brands now under the ministry’s examination include Pfizer’s Bendryl Couph Syrup and Caladryl lotion for itching and Eli Lilly’s Human Insulin.

Cadila Pharma’s anti-ulcer medicine Ranitidine, Ranbaxy’s pain killer Pentazocine and antibiotic Roscillin, anti-bacterial Cilanem and impotence drug Caverta, Pfizer’s medicine for irritation and itching Caladryl lotion are also believed to be under the government’s review.

Source: Economic Times


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: